Dong-A Dementia Center is determined to strive to provide 
				hope to dementia patients and their families by discovering and developing innovative therapies.
  • twitter
  • facebook
  • print

Biologics

We have built an expertise platform in genetic
engineering for developing biological drugs.
We are interested in advancing promising therapeutic
protein and antibody therapeutics for dementia.

Due to the high specificity, protein and antibody drugs
are expected to exert neuroprotective and regenerative
effects in a safer fashion.

Areas of Interest

  • Therapeutic antibody with a novel target or mechanism
  • Neuronal protection, growth, and regeneration